Craig Safian - 31 Jul 2024 Form 4 Insider Report for GARTNER INC (IT)

Role
EVP & CFO
Signature
/s/ Kevin Tang for Craig Safian
Issuer symbol
IT
Transactions as of
31 Jul 2024
Net transactions value
-$3,298,434
Form type
4
Filing time
02 Aug 2024, 16:32:22 UTC
Previous filing
04 Jun 2024
Next filing
19 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IT Common Stock Options Exercise $1,887,160 +13,196 +18% $143.01 84,740 31 Jul 2024 Direct F1
transaction IT Common Stock Disposed to Issuer $1,887,482 -3,766 -4.4% $501.19 80,974 31 Jul 2024 Direct F2
transaction IT Common Stock Tax liability $2,412,729 -4,814 -5.9% $501.19 76,160 31 Jul 2024 Direct F3
transaction IT Common Stock Options Exercise $771,550 +5,000 +6.6% $154.31 81,160 31 Jul 2024 Direct F1
transaction IT Common Stock Disposed to Issuer $771,833 -1,540 -1.9% $501.19 79,620 31 Jul 2024 Direct F2
transaction IT Common Stock Tax liability $885,102 -1,766 -2.2% $501.19 77,854 31 Jul 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IT Stock Appreciation Rights Options Exercise $0 -13,196 -100% $0.000000* 0 31 Jul 2024 Common Stock 13,196 $143.01 Direct F4
transaction IT Stock Appreciation Rights Options Exercise $0 -5,000 -19% $0.000000 20,657 31 Jul 2024 Common Stock 5,000 $154.31 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of SARs.
F2 Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.
F3 Represents shares withheld for the payment of applicable income and payroll withholding taxes.
F4 These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 6, 2020, and are fully exercisable.
F5 These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 5, 2021, and are fully exercisable.